Last edition
News about "MenQuadfi"
European Commission Expands Sanofi's MenQuadfi Approval to Include Infants from Six Weeks of Age
The European Commission has approved an expanded indication for Sanofi's MenQuadfi vaccine, allowing immunisation of infants from six weeks of age against invasive meningococcal disease caused by serogroups A, C, W and Y.
MenQuadfi | 05/08/2026 | By News Bureau
EU Approves Sanofi's MenQuadfi for Invasive Meningococcal Disease
Sanofi's MenQuadfi has received European Union (EU) approval for infants from 6 weeks of age, expanding protection against invasive meningococcal disease.
MenQuadfi | 04/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy